Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial.
Leclercq C, Burri H, Delnoy PP, Rinaldi CA, Sperzel J, Calò L, Concha JF, Fusco A, Al Samadi F, Lee K, Thibault B.
Europace. 2023 Oct 5;25(10):euad294. doi: 10.1093/europace/euad294.
PMID:37776313
Timing of cardiac resynchronization therapy implantation.
Leyva F, Zegard A, Patel P, Stegemann B, Marshall H, Ludman P, Walton J, de Bono J, Boriani G, Qiu T.
Europace. 2023 May 19;25(5):euad059. doi: 10.1093/europace/euad059.
PMID:36944529
Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre, observational study.
Chen X, Ye Y, Wang Z, Jin Q, Qiu Z, Wang J, Qin S, Bai J, Wang W, Liang Y, Chen H, Sheng X, Gao F, Zhao X, Fu G, Ellenbogen KA, Su Y, Ge J.
Europace. 2022 May 3;24(5):807-816. doi: 10.1093/europace/euab249.
PMID:34718539
Lessons learned from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Cardiac resynchronization therapy response in cardiac sarcoidosis.
Shabtaie SA, Sehrawat O, Lee JZ, Cha YM, Mulpuru SK, Kowlgi NG, Siontis KC, Rosenbaum AN, Bois JP, AbouEzzeddine OF, Noseworthy PA, Asirvatham SJ, DeSimone CV, Deshmukh AJ.